BridgeBio Pharma Secures $1.25B For New Drug Launch

By Yeji Jesse Lee · January 18, 2024, 6:41 PM EST

Public biopharmaceutical company BridgeBio Pharma announced Thursday that it has raised up to $1.25 billion in capital from Blue Owl Capital and the Canada Pension Plan Investment Board to accelerate the...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login